Omada Health (OMDA) is a Medical - Healthcare Information Services company in the Healthcare sector, currently trading at $12.46. It has a SharesGrow Score of 63/100, indicating a above average investment profile with 3 out of 7 criteria passed.
SharesGrow calculates the intrinsic value of OMDA = $9.58 (-23.1% from the current price, the stock appears overvalued). Analyst consensus target is OMDA = $25 (+99% upside).
Valuation: OMDA trades at a trailing Price-to-Earnings (P/E) of -54.4 (S&P 500 average ~25) with a forward Price/Earnings-to-Growth (PEG) of 0.7.
Financials: revenue is $260M, +43.1%/yr average growth. Net income is $13M (loss), growing at +36.7%/yr. Net profit margin is -4.9% (negative). Gross margin is 65.5% (+17.5 pp trend).
Balance sheet: total debt is $0 against $230M equity (Debt-to-Equity (D/E) ratio 0, conservative). Current ratio is 3.6 (strong liquidity). Debt-to-assets is 0%. Total assets: $305M.
Analyst outlook: 8 / 8 analysts rate OMDA as buy (100%) — strong consensus.
SharesGrow 7-Criteria breakdown: Value 100/100 (Pass), Growth 100/100 (Pass), Past 0/100 (Fail), Health 67/100 (Partial), Moat 64/100 (Partial), Future 100/100 (Pass), Income 10/100 (Fail).
